Tango Therapeutics Inc [NASDAQ: TNGX] loss -37.45% on the last trading session, reaching $3.24 price per share at the time.
If compared to the average trading volume of 1.05M shares, TNGX reached a trading volume of 14877716 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Tango Therapeutics Inc [TNGX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNGX shares is $13.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNGX stock is a recommendation set at 1.11. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Tango Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 17, 2024. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 04, 2024, representing the official price target for Tango Therapeutics Inc stock. Previously, the target price had yet another raise to $18, while Piper Sandler analysts kept a Overweight rating on TNGX stock.
The Average True Range (ATR) for Tango Therapeutics Inc is set at 0.60, with the Price to Sales ratio for TNGX stock in the period of the last 12 months amounting to 8.17. The Price to Book ratio for the last quarter was 1.40, with the Price to Cash per share for the same quarter was set at 3.01.
Trading performance analysis for TNGX stock
Tango Therapeutics Inc [TNGX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -43.26. With this latest performance, TNGX shares dropped by -52.98% in over the last four-week period, additionally sinking by -59.04% over the last 6 months – not to mention a drop of -61.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNGX stock in for the last two-week period is set at 15.33, with the RSI for the last a single of trading hit 8.96, and the three-weeks RSI is set at 21.43 for Tango Therapeutics Inc [TNGX]. The present Moving Average for the last 50 days of trading for this stock 7.74, while it was recorded at 4.83 for the last single week of trading, and 8.84 for the last 200 days.
Tango Therapeutics Inc [TNGX]: A deeper dive into fundamental analysis
Tango Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.49 and a Current Ratio set at 7.49.
An analysis of Institutional ownership at Tango Therapeutics Inc [TNGX]
There are presently around $89.03%, or 102.19%% of TNGX stock, in the hands of institutional investors. The top three institutional holders of TNGX stocks are: TRV GP IV, LLC with ownership of 19.2 million shares, which is approximately 17.751%. ECOR1 CAPITAL, LLC, holding 13.33 million shares of the stock with an approximate value of $$114.38 million in TNGX stocks shares; and ECOR1 CAPITAL, LLC, currently with $$80.73 million in TNGX stock with ownership which is approximately 8.6983%.
